Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Susan Jin"'
Autor:
Gregory M. Christman, Karl R. Hansen, Esther Eisenberg, Ruben Alvero, Nanette Santoro, Michael P. Diamond, Clarisa R. Gracia, Aimee Seungdamrong, Susan Jin, Randal D. Robinson, Peter R. Casson, William D. Schlaff, Heping Zhang, Christos Coutifaris, Hao Huang, Richard S. Legro, Anne Z. Steiner
Publikováno v:
Fertility and Sterility. 108:843-850
OBJECTIVE: To study whether preconceptual thyroid-stimulating hormone (TSH) and antithyroid peroxidase (TPO) antibodies are associated with poor reproductive outcomes in infertile women. DESIGN: Secondary analysis of data from two multicenter, random
Publikováno v:
Therapeutic innovationregulatory science. 54(4)
Over the past 20 years, there has been increasing interest in the use of Bayesian statistical methods for the analysis of clinical trials used to support regulatory decisions. Bayesian methods for the analysis of clinical trials are an attractive opt
Autor:
Alex J. Polotsky, Karl R. Hansen, Ruben Alvero, Michael P. Diamond, Susan Jin, Wendy Vitek, Gregory M. Christman, Heping Zhang, Nanette Santoro, Esther Eisenberg, Mindy S. Christianson, Fangbai Sun, Richard S. Legro, Peter R. Casson, Alicia Y. Christy, Aaron K. Styer, Elizabeth E. Puscheck, Christos Coutifaris
PURPOSE: To compare saline infusion sonohysterography (SIS) versus hysterosalpingogram (HSG) for confirmation of tubal patency. METHODS: Secondary analysis of a randomized controlled trial, Pregnancy in Polycystic Ovary Syndrome II (PPCOS II). Seven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f14dba779bb10f729cdf0b4d4baea3da
https://europepmc.org/articles/PMC6289919/
https://europepmc.org/articles/PMC6289919/
Publikováno v:
Therapeutic innovationregulatory science. 53(1)
Advanced and metastatic melanoma has historically been one of the most difficult cancers to treat, with few treatment options. For over 20 years, dacarbazine chemotherapy was the only treatment approved by the US Food and Drug Administration for mela
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35(33)
Clinical trial eligibility criteria are necessary to define the patient population under study and improve trial safety. However, there are concerns that eligibility criteria for cancer clinical trials are too restrictive and limit patient enrollment
Autor:
Ann T. Farrell, Susan Jin, Theresa Carioti, Kunthel By, Bindu Kanapuru, Rajeshwari Sridhara, Nicole J. Gormley, Richard Pazdur, Yuan-Li Shen
Publikováno v:
Blood. 134:3194-3194
Background: Multiple novel therapies have been approved for the treatment of RRMM in recent years, resulting in improvements in progression free survival (PFS) and overall survival (OS). However, clinical trials in MM often enroll only a small propor
Autor:
Gregory M. Christman, J. C. Trussell, Randal D. Robinson, Esther Eisenberg, Michael P. Diamond, Clarisa R. Gracia, Susan Jin, Nanette Santoro, LaTasha B. Craig, Ruben Alvero, Christos Coutifaris, Heping Zhang, Richard S. Legro, Hao Huang, Peter R. Casson, William D. Schlaff
Publikováno v:
Human reproduction (Oxford, England). 31(10)
STUDY QUESTION Does fertility-related quality of life (FertiQOL) differ by infertility diagnosis between women with polycystic ovary syndrome (PCOS) and their partners, compared with couples with unexplained infertility (UI)? SUMMARY ANSWER Women wit
Autor:
Kunthel By, Nicole J. Gormley, Susan Jin, Bindu Kanapuru, Richard Pazdur, Theresa Carioti, Yuan Li Shen, Ann T. Farrell
Publikováno v:
Blood. 132:3287-3287
Background: Multiple myeloma (MM) is a disease of older adults with a median age of onset of 70 years. Approximately 20% of the incident cases are diagnosed in patients 85 years and older. There is significant heterogeneity among older adults with re
Autor:
Hongying Kuang, Susan Jin, Tracey Thomas, Lawrence Engmann, Karl R. Hansen, Christos Coutifaris, Peter Casson, Gregory Christman, Ruben Alvero, Nanette Santoro, Esther Eisenberg, Michael P. Diamond, Richard S. Legro, Heping Zhang, C. Bartlebaugh, W. Dodson, S. Estes, C. Gnatuk, R. Ladda, J. Ober, C. Easton, A. Hernandez, M. Leija, D. Pierce, R. Bryzski, A. Awonuga, L. Cedo, A. Cline, K. Collins, S.A. Krawetz, E. Puscheck, M. Singh, M. Yoscovits, K. Barnhart, K. Lecks, L. Martino, R. Marunich, P. Snyder, W.D. Schlaff, A. Comfort, M. Crow, A. Hohmann, S. Mallette, M. Ringbloom, J. Tang, S. Mason, N. DiMaria, M. Rhea, K. Turner, D.J. Haisenleder, J.C. Trussell, D. DelBasso, Y. Li, R. Makuch, P. Patrizio, L. Sakai, L. Scahill, H. Taylor, T. Thomas, S. Tsang, M. Zhang, C. Lamar, L. DePaolo, D. Guzick, A. Herring, J. Bruce Redmond, M. Thomas, P. Turek, J. Wactawski-Wende, R. Rebar, P. Cato, V. Dukic, V. Lewis, P. Schlegel, F. Witter
Objective To identify variables associated with retention (or dropout) in infertility clinical trials. Retention of subjects in randomized controlled clinical trials (RCTs) has received considerable attention, but there have been few consistent findi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7611c1abcdcb019f344f38774a592dba
https://europepmc.org/articles/PMC4630082/
https://europepmc.org/articles/PMC4630082/
Autor:
Peter Casson, Valerie L. Baker, Gregory M. Christman, Scott Lucidi, Karl R. Hansen, Hongying Kuang, Rebecca S. Usadi, Michael P. Diamond, Hao Huang, Heping Zhang, G. Wright Bates, Susan Jin, Ruben Alvero, Christos Coutifaris, Richard S. Legro, Esther Eisenberg, Nanette Santoro
Study question Can we build and validate predictive models for ovulation and pregnancy outcomes in infertile women with polycystic ovary syndrome (PCOS)? Summary answer We were able to develop and validate a predictive model for pregnancy outcomes in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e804bdbf0e6aba3848c5770253c0040
https://europepmc.org/articles/PMC4542721/
https://europepmc.org/articles/PMC4542721/